IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: AMAG Pharmaceuticals
Symbol: AMAG
Price: Last trade $64.95
Trade Date: 7/31
Shares: 3 million
Underwriter(s) Jefferies, Barclays Capital
Rating=Subscription Needed
Company: RAIT Financial
Symbol: RAS
Price: Last trade $5.82
Trade Date: 7/31
Shares: 8 million
Underwriter(s) Barclays Capital, UBS Securities
Rating=Subscription Needed
Company: Quintiles Transnational Holdings-BLOCK
Symbol: Q
Price: Last trade $78.75
Trade Date: 7/31
Shares: 7 million
Underwriter(s) Morgan Stanley
Rating=Subscription Needed
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish